| 查看: 1037 | 回复: 5 | |||
| 本帖产生 1 个 翻译EPI ,点击这里进行查看 | |||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | |||
wqssfj1铁杆木虫 (著名写手)
|
[求助]
求助翻译
|
||
|
However, an evaluation of all reports related to skin events received by Novartis from marketed use of vildagliptin (includes Galvus and Eucreas) since the original placing on the market to 29 Feb 2012 was performed and as post-marketing experience “Localized exfoliation or blisters” (frequency not known) were added as the adverse drug reactions in the current CDS. 分析句子成份加翻译,谢谢! |
» 收录本帖的淘帖专辑推荐
精品翻译集锦 |
» 猜你喜欢
闲聊
已经有6人回复
江苏省自然基金 什么时候出结果
已经有7人回复
浙江师范大学是怎么坑我的
已经有10人回复
浙江师范大学是怎么坑我的
已经有3人回复
求教各位大神:2026教育部人文社科青年基金项目何时公示呀?
已经有6人回复
面上有专家说实验设备不是我们单位的
已经有8人回复
科研求助
已经有4人回复
17953216334
银虫 (小有名气)
- 翻译EPI: 1
- 应助: 5 (幼儿园)
- 金币: 1241.8
- 红花: 3
- 帖子: 130
- 在线: 116.5小时
- 虫号: 1787064
- 注册: 2012-04-30
- 专业: 高分子助剂
4楼2012-06-25 13:24:01
qin20010
木虫 (小有名气)
小木虫博士生导师
- 应助: 0 (幼儿园)
- 金币: 2012.8
- 帖子: 275
- 在线: 27.4小时
- 虫号: 346589
- 注册: 2007-04-15
- 性别: GG
- 专业: 催化化学

2楼2012-06-25 10:59:20
wqssfj1
铁杆木虫 (著名写手)
- 翻译EPI: 1
- 应助: 2 (幼儿园)
- 金币: 5947.4
- 散金: 21
- 红花: 3
- 帖子: 1448
- 在线: 252.5小时
- 虫号: 1391164
- 注册: 2011-09-05
- 专业: 药物资源
3楼2012-06-25 13:15:47
readbycandle
木虫 (著名写手)
A thinking worm
- 翻译EPI: 55
- 应助: 22 (小学生)
- 贵宾: 0.2
- 金币: 7100.6
- 红花: 13
- 帖子: 2158
- 在线: 460.5小时
- 虫号: 1793835
- 注册: 2012-05-03
- 专业: 美国文学
【答案】应助回帖
|
However, an evaluation of all reports related to skin events received by Novartis from marketed use of vildagliptin (includes Galvus and Eucreas) since the original placing on the market to 29 Feb 2012 was performed and as post-marketing experience “Localized exfoliation or blisters” (frequency not known) were added as the adverse drug reactions in the current CDS. 这是两个并列的句子。an evaluationketed....was performed and “Localized exfoliation or blisters” were added . 翻译: However, an evaluation of all reports related to skin events received by Novartis from marketed use of vildagliptin (includes Galvus and Eucreas) since the original placing on the market to 29 Feb 2012 was performed 不过,已对自投放市场以来至2012年2月29日诺华公司收到的关于使用vildagliptin (包括Galvus and Eucreas)引起的皮肤反应的所有报告进行了评估, and as post-marketing experience “Localized exfoliation or blisters” (frequency not known) were added as the adverse drug reactions in the current CDS. 并将“可以引起局部脱皮或水泡”作为市场反馈信息加入目前CDS的副作用说明中。 |
5楼2012-06-28 17:36:35









回复此楼